Equities

Qol Holdings Co Ltd

3034:TYO

Qol Holdings Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)1,794.00
  • Today's Change-2.00 / -0.11%
  • Shares traded32.00k
  • 1 Year change+43.52%
  • Beta0.7835
Data delayed at least 20 minutes, as of May 02 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Qol Holdings Co.,Ltd., formerly Qol Co., Ltd. is engaged in the operation of insurance pharmacies and Business Process Outsourcing (BOP) commission business. The Company operates in two segments. The Insurance Pharmacy segment is engaged in the operation of insurance pharmacies, as well as the operation of convenience stores in hospitals. The BOP Commission segment is engaged in the Contract Sales Organization (CSO) business, Contract Research Organization (CRO) business, medical related business and the wholesale of medicine products, cosmetic products and daily necessities through its subsidiaries.

  • Revenue in JPY (TTM)178.46bn
  • Net income in JPY5.27bn
  • Incorporated1992
  • Employees5.75k
  • Location
    Qol Holdings Co Ltd37FShiroyama Trust Tower, 4-3-1, ToranomonMINATO-KU 105-8452JapanJPN
  • Phone+81 354059011
  • Websitehttps://www.qolhd.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
3034:TYO since
announced
Transaction
value
Harigawa Chozai Yakkyoku YugengaishaDeal completed21 Nov 202321 Nov 2023Deal completed10.54%--
Yugengaisha AM MedicalDeal completed21 Nov 202321 Nov 2023Deal completed10.54%--
Yugengaisha ArtDeal completed21 Nov 202321 Nov 2023Deal completed10.54%--
Daiichi Sankyo Espha Co LtdAnnounced16 May 202316 May 2023Announced50.38%183.68m
Data delayed at least 20 minutes, as of May 02 2024 07:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medical System Network Co Ltd113.85bn2.11bn19.34bn3.62k9.031.223.690.169869.8569.853,772.48515.661.6710.6232.3431,458,410.003.121.774.832.7241.7440.131.861.100.613813.550.602628.572.693.11-32.759.52-17.643.71
Nihon Chouzai Co Ltd340.31bn2.55bn42.47bn5.69k16.030.70143.660.124885.3485.3411,375.311,950.411.797.6215.53--1.342.272.343.9416.8217.260.75021.400.623925.750.484917.878.616.73-42.73-7.6012.040.00
Yakuodo Holdings Co Ltd142.24bn3.83bn55.88bn969.0014.501.678.410.3929195.20195.207,259.051,700.132.054.8587.88--5.525.548.438.6721.5722.402.692.720.3559168.030.289814.3610.449.1518.025.37-15.284.36
Cawachi Ltd285.96bn4.71bn68.88bn2.77k13.290.56237.640.2409210.78210.7812,788.754,983.151.466.5033.52--2.412.573.543.8223.0122.571.651.760.8316580.380.130724.451.451.4712.8318.5114.1912.20
Qol Holdings Co Ltd178.46bn5.27bn69.79bn5.75k12.651.306.680.3911141.81141.814,801.101,384.571.6121.8710.7131,058,650.004.764.707.907.5413.0713.202.952.840.9217--0.362524.302.313.163.042.5520.482.90
Genky DrugStores Co Ltd181.44bn5.91bn87.22bn1.75k14.491.9110.240.4807388.47388.4711,932.202,948.951.746.6951.56103,503,100.005.684.618.637.4020.3121.183.262.810.34992.800.41369.769.3212.257.778.8513.4214.87
AIN Holdings Inc391.20bn11.34bn220.40bn10.65k19.281.6410.080.5634322.68322.6811,135.343,791.571.6513.1730.9636,728,570.004.794.108.126.6614.6315.712.902.680.7907--0.0423.9713.445.9830.20-2.6626.793.71
Create SD Holdings Co Ltd411.72bn13.90bn227.85bn4.73k15.941.7312.170.5534213.90213.906,326.441,970.862.148.1032.1887,025,370.007.227.6210.8512.1126.2827.443.383.570.8374--0.0023.018.627.272.626.2619.378.87
Kusuri No Aoki Holdings Co Ltd423.36bn8.64bn273.34bn4.46k31.652.4312.820.645791.2991.294,475.411,191.111.567.0042.3894,923,100.003.186.144.609.4927.3528.262.043.660.770465.450.42476.3715.3911.3525.286.927.9012.63
Data as of May 02 2024. Currency figures normalised to Qol Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

15.89%Per cent of shares held by top holders
HolderShares% Held
Templeton Investment Counsel LLCas of 15 Feb 20231.67m4.30%
Nomura Asset Management Co., Ltd.as of 29 Mar 2024880.50k2.26%
Fidelity Management & Research Co. LLCas of 31 May 2023849.34k2.18%
The Vanguard Group, Inc.as of 05 Apr 2024765.90k1.97%
Dimensional Fund Advisors LPas of 04 Apr 2024432.20k1.11%
Cedar Street Asset Management LLCas of 31 Jan 2024416.16k1.07%
Nikko Asset Management Co., Ltd.as of 05 Apr 2024415.90k1.07%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024406.40k1.05%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024172.00k0.44%
Norges Bank Investment Managementas of 31 Dec 2023170.70k0.44%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.